Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers

INTRODUCTION: Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia. In the European Union, approximately 40% of people with schizophrenia have TRS. Factors such as the persistence of positive symptoms or higher risk of comorbidities leave clinicians with a complex scenario when...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso-Solís, Anna, Rubinstein, Katya, Corripio, Iluminada, Jaaskelainen, Erika, Seppälä, Annika, Vella, Vincenzo Alberto, Caro-Mendivelso, Johanna, Caspi, Asaf, Isohanni, Matti, Unoka, Zsolt, Van der Graff, Shenja, Farkas, Kinga, Huerta-Ramos, Elena, Marcó-García, Silvia, Stevens, Matthias, Coenen, Tanguy, Hospedales, Margarita, Berdún, Jesús, Grasa, Eva M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Mental Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082494/
https://www.ncbi.nlm.nih.gov/pubmed/30012788
http://dx.doi.org/10.1136/bmjopen-2017-021346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082494/
https://www.ncbi.nlm.nih.gov/pubmed/30012788
http://dx.doi.org/10.1136/bmjopen-2017-021346

Ejemplares similares